Soquinolol
Alternative Names: WE 704Latest Information Update: 24 Jan 2013
At a glance
- Originator Unknown
- Developer AbbVie
- Class Heart failure therapies
- Mechanism of Action Beta adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 01 Aug 1997 Discontinued-preregistration for Heart failure (Unknown route)